triptolide

Small moleculeexperimental

Triptolide is a diterpenoid epoxide which is produced by the thunder god vine, Tripterygium wilfordii. It has in vitro and in vivo activities against mouse models of polycystic kidney disease and pancreatic cancer, but its physical properties and severe toxicity limit its therapeutic potential. Consequently, a synthetic water-soluble prodrug, minnelide, is being studied clinically instead. — Wikipedia

Clinical trial activity

4 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
4
Phase 3
3
Phase 4
0

Earliest trial started Jan 1, 2013 (NCT01817283)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2014

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Loading structure…

SMILES

CC(C)[C@]12O[C@H]1[C@@H]1O[C@]13[C@]1(O[C@H]1C[C@H]1C4=C(CC[C@@]13C)C(=O)OC4)[C@@H]2O
Mol. weight
360.41 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • pg490
  • triplitode
  • triptolide
  • triptolide
  • triptolide
  • triptolide

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03403569Phase 3Aug 1, 2018Chinese Academy of Medical Sciences
NCT02219672Phase 3Jul 1, 2014Government of China, Tsinghua University
NCT02115659Phase 3Apr 1, 2014Second Military Medical University
NCT01817283Phase 1/Phase 2 (Phase 2)Jan 1, 2013Peking University, Tsinghua University
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Tsinghua UniversityAcademic/Hospital2122013
Chinese Academy of Medical SciencesAcademic/Hospital1112018
Government of ChinaGovernment1012014
Peking UniversityAcademic/Hospital1112013
Second Military Medical UniversityGovernment1112014
5 organizations
Page 1 / 1